Active Shortage Injection Anesthesia

Ropivacaine Hydrochloride In · 3,103 days since initial FDA posting

Brand: NAROPIN

FDA lists Ropivacaine Hydrochloride In as Active Shortage (Fresenius Kabi USA, LLC).

Availability on file: Unavailable

Ropivacaine Hydrochloride Injection: Active Shortage

Unavailable Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Ropivacaine Hydrochloride Injection
Manufacturer
Fresenius Kabi USA, LLC
Dosage Form
Injection
Presentation
Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)
Package NDC
63323-285-61

Status & Timeline

Status
Active Shortage
Availability
Unavailable
First Reported
Mar 23, 2018
Last Updated
Mar 17, 2026
Therapeutic Category
Anesthesia

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Expected recovery: TBD

Nearby, Other Ropivacaine Shortage Records

Ropivacaine Hydrochloride Injection

InfoRLife SA

Injection

Active Shortage

Ropivacaine Hydrochloride Injection

InfoRLife SA

Injection

Active Shortage

Ropivacaine Hydrochloride Injection

InfoRLife SA

Injection

Active Shortage

Ropivacaine Hydrochloride Injection

InfoRLife SA

Injection

Active Shortage

Ropivacaine Hydrochloride Injection

InfoRLife SA

Injection

Active Shortage

Ropivacaine Hydrochloride Injection

InfoRLife SA

Injection

Active Shortage

FDA reason on file: Expected recovery: TBD. General shortage guidance lives on the tracker hub.

← All Drug Shortages